Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis

• Published in: Skeletal radiology 2016-09, Vol.45 (9), p.1235-1242
• Main Authors: Kubo, Tadahiko, Furuta, Taisuke, Johan, Muhammad P., Adachi, Nobuo, Ochi, Mitsuo
• Format: Article
• Language: English
• Subjects: Adjuvant treatment; Bone Neoplasms - diagnostic imaging; Bone Neoplasms - drug therapy; Cancer; Humans; Imaging; Magnetic Resonance Imaging; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Neoadjuvant Therapy; Nuclear Medicine; Orthopedics; Osteosarcoma; Osteosarcoma - diagnostic imaging; Osteosarcoma - drug therapy; Pathology; Radiology; Sarcoma, Ewing - diagnostic imaging; Sarcoma, Ewing - drug therapy; Scientific Article; Sensitivity and Specificity; Statistics
• ISSN: 0364-2348; 1432-2161
• DOI: 10.1007/s00256-016-2410-y

Objective The objective of this systematic review is to provide an up-to-date and unprecedented summary of percent slope analysis of dynamic magnetic resonance imaging (MRI) for the preoperative evaluation of the chemotherapy response of osteosarcoma or Ewing sarcoma. Materials and method Studies evaluating dynamic MRI for the preoperative evaluation of the chemotherapy response of osteosarcoma or Ewing sarcoma were systematically searched for in MEDLINE, EMBASE, and Web of Science. More than 60 % reduction of the slope of the time intensity curve derived from dynamic MRI was defined as a positive response. Pooled sensitivity and specificity for each study were calculated into 2 × 2 contingency tables. The DerSimonian-Laird random-effects method was used for determining the pooled diagnostic odds ratio and the area under curve (AUC) of the summary receiver operating characteristic (SROC) curve. Results A total of six studies with 66 patients who fulfilled all of the inclusion criteria were considered for the meta-analysis. The pooled sensitivity and specificity were 0.73 (95 % CI, 0.54–0.88) and 0.83 (95 % CI, 0.67–0.94), respectively. A significant difference was found between the good and poor responders in the diagnostic odds ratio. The SROC curve showed that the AUC was 0.839, indicating diagnostic accuracy in estimating good therapy response. Conclusion The slope of the time intensity curve derived from dynamic MRI was useful for evaluating the histological response of patients to neoadjuvant chemotherapy in osteosarcoma or Ewing sarcoma.